Chemed Corporation (CHE) Reached 52-Week High on May, 16 at $332.05

May 16, 2018 - By Robert Reynolds

During Q4 2017 the big money sentiment decreased to 0.96. That’s change of 0.08, from 2017Q3’s 1.04. 18 investors sold all, 94 reduced holdings as Chemed Corporation ratio fall. 58 increased stakes while 49 funds amassed stakes. Funds hold 14.86 million shares thus 3.45% less from 2017Q3’s 15.40 million shares.
Fifth Third National Bank invested in 543 shs or 0% of the stock. Gemmer Asset Management Lc accumulated 0% or 21 shs. Clarivest Asset Mgmt Limited Liability Company has invested 0.08% in Chemed Corporation (NYSE:CHE). Rhumbline Advisers holds 0.03% or 54,149 shs in its capital. Zurcher Kantonalbank (Zurich Cantonalbank) reported 984 shs. Stratos Wealth Ptnrs invested 0% in Chemed Corporation (NYSE:CHE). Renaissance Techs Limited Liability Corporation holds 0.01% or 54,400 shs in its capital. Suntrust Banks stated it has 0% in Chemed Corporation (NYSE:CHE). Northwestern Mutual Wealth Mngmt Company stated it has 9 shs. Apg Asset Management Nv has invested 0.01% of its capital in Chemed Corporation (NYSE:CHE). Stevens Mngmt L P holds 2,960 shs. The Arkansas-based Stephens Ar has invested 0.01% in Chemed Corporation (NYSE:CHE). Geode Capital Management Lc holds 166,265 shs or 0.01% of its capital. Iowa Bank has invested 0.21% in Chemed Corporation (NYSE:CHE). 3,596 were accumulated by Tower Ltd Liability (Trc).

Chemed Corporation had 13 sales and 0 insider purchases since January 12, 2018. This’s net activity of $27.86 million. 1,000 Chemed Corporation (NYSE:CHE) shs with value of $313,000 were sold by Witzeman Michael D. On Tuesday, April 24 Dallob Naomi C sold $91,476 worth of Chemed Corporation (NYSE:CHE). On Thursday, April 26 SAUNDERS DONALD E sold $107,864 worth of Chemed Corporation (NYSE:CHE). LEE SPENCER S sold $428,257 worth of stock or 1,428 shs. On Tuesday, April 24 MCNAMARA KEVIN J sold $6.59M worth of Chemed Corporation (NYSE:CHE). On Wednesday, May 2 $4.04 million worth of Chemed Corporation (NYSE:CHE) was sold by Westfall Nicholas Michael.

Today Chemed Corporation (NYSE:CHE) with $332.05 stock price, reached yearly high with $355.29 PT or 7.00 % above. On May, 16 it was reported by Barchart.com. Chemed Corporation (NYSE:CHE) has $5.29B MC. At $355.29 PT, the company’s valuation could be $370.44M more.

CHE touched $332.05 during the last trading session after $5.62 change.Chemed Corporation has volume of 105,172 shares. Since May 16, 2017 CHE has risen 48.33% and is uptrending. The stock outperformed the S&P500 by 36.78%.

Chemed Corporation (NYSE:CHE)’s earnings report is anticipated by WallStreet on July, 24, RTT reports. earnings per share of $2.68 is 24.65 % up from 2017’s $2.15 EPS. If the current earnings per share of $2.68 is accurate, CHE’s profit could hit $42.71M. After $2.72 earnings per share was published last quarter, analysts now see negative EPS growth of -1.47 % for Chemed Corporation.

More recent Chemed Corporation (NYSE:CHE) news were published by Globenewswire.com, Seekingalpha.com and Benzinga.com. The first one has “VITAS HEALTHCARE JOINS AMERICAN HOSPITAL ASSOCIATION” as a title and was published on May 07, 2018. The next is “Chemed’s (CHE) CEO Kevin McNamara on Q1 2018 Results – Earnings Call Transcript” on April 20, 2018. And last was published on April 19, 2018, called “Earnings Scheduled For April 19, 2018”.

Chemed Corporation provides hospice and palliative care services in the United States.The firm is worth $5.29 billion. It operates through two divisions, VITAS and Roto-Rooter.The P/E ratio is 56.66. The firm offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers.

Chemed Corporation (NYSE:CHE) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: